AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Gentian Diagnostics ASA

Director's Dealing Feb 28, 2019

3604_dirs_2019-02-28_dd5a2a10-1fad-4dd4-b576-e0af5f15abe7.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Primary insider notification

Primary insider notification

Moss, 28 February 2019

Njaal Kind, Chief Financial Officer of Gentian Diagnostics AS, has today acquired 10,000 shares in Gentian Diagnostics AS at an average price of NOK 56.00 per share.

Following this share purchase Mr. Kind owns 10,000 shares and 34,991 options in Gentian Diagnostics AS.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.

Talk to a Data Expert

Have a question? We'll get back to you promptly.